News · 4 views

Immune Resetting : B - Cell Mediated & Beyond Summit 2026 Oral Presentation : Innovent Biologics Announces Pre - Clinical Results of IBI3055 , a Tri - specific T Cell Engager Targeting Autoimmune Diseases

/PRNewswire/ -- Innovent Biologics, Inc.

Source prnewswire.com AI Summary Updated April 10, 2026

Story intelligence Beta

Freshness Stale Updated April 10, 2026

Confidence Limited Single-outlet story

Coverage Single outlet

Views 4 Community interest

Read time 1 min ~17 words

AI Summary

/PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes...

Read full article on Prnewswire

AI summaries can be wrong sometimes—always verify important details using the source article.

SUPPORT HAPPENINGNOW · Independent AI News Intelligence

SUPPORTER MESSAGE

Enjoyed this article? Consider supporting HappeningNow to help keep independent AI-powered news analysis moving forward. Your contribution helps cover infrastructure, AI summaries, and continued platform development.

Support HappeningNow